Market Value239,627,000
Total Holdings80
File Date2020-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EVLO / Evelo Biosciences, Inc.
INSM / Insmed Incorporated
DRNA / Dicerna Pharmaceuticals Inc
ZYME / Zymeworks Inc.
US55027E1029 / Luminex Corporation
AGTC / Applied Genetic Technologies Corp
EPZM / Epizyme Inc
RDUS / Radius Recycling, Inc.
TPTX / Turning Point Therapeutics Inc
XCUR / Exicure, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
SIOX / Sio Gene Therapies Inc.
JNJ / Johnson & Johnson
NXTC / NextCure, Inc.
GMDA / Gamida Cell Ltd.
US252131AF44 / Dexcom Inc Bond
ZGNX / Zogenix Inc
BTAI / BioXcel Therapeutics, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
ADXS / Ayala Pharmaceuticals, Inc.
GRTS / Gritstone bio, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
ARQL / ArQule, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
KDMN / Kadmon Holdings Inc
US0906721065 / BioTelemetry, Inc.
US74140Y1010 / Prevail Therapeutics Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
US750469AA69 / Radius Health, Inc. Bond
SYBX / Synlogic, Inc.
TPST / Tempest Therapeutics, Inc.
BHVN / Biohaven Ltd.
STRO / Sutro Biopharma, Inc.
TBIO / Telesis Bio, Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
TCRR / Tcr2 Therapeutics Inc
NTUS / Natus Medical Inc
MDGL / Madrigal Pharmaceuticals, Inc.
ELOX / Eloxx Pharmaceuticals, Inc.
ARNA / Arena Pharmaceuticals Inc
GNCA / Genocea Biosciences Inc
ASMB / Assembly Biosciences, Inc.
WVE / Wave Life Sciences Ltd.
AERI / Aerie Pharmaceuticals Inc
APLS / Apellis Pharmaceuticals, Inc.
HARP / Harpoon Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
FATE / Fate Therapeutics, Inc.
LCTX / Lineage Cell Therapeutics, Inc.
AFMD / Affimed N.V.
MRTX / Mirati Therapeutics, Inc.
AKBA / Akebia Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
ARDX / Ardelyx, Inc.
CSII / Cardiovascular Systems Inc.
OTIC / Otonomy Inc
CARA / Cara Therapeutics, Inc.
BLUE / bluebird bio, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
KRTX / Karuna Therapeutics, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
MRSN / Mersana Therapeutics, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
CTMX / CytomX Therapeutics, Inc.
KURA / Kura Oncology, Inc.
STXS / Stereotaxis, Inc.
URGN / UroGen Pharma Ltd.
DXCM / DexCom, Inc.
NBIX / Neurocrine Biosciences, Inc.
SAGE / Sage Therapeutics, Inc.
MGNX / MacroGenics, Inc.
RCUS / Arcus Biosciences, Inc.
INGN / Inogen, Inc.
ALEC / Alector, Inc.
MORF / Morphic Holding, Inc.
KALV / KalVista Pharmaceuticals, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
MASI / Masimo Corporation
SPRO / Spero Therapeutics, Inc.
ATRC / AtriCure, Inc.
STIM / Neuronetics, Inc.
ARAY / Accuray Incorporated
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
VYNE / VYNE Therapeutics Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
CGEN / Compugen Ltd.
BPMC / Blueprint Medicines Corporation
XENE / Xenon Pharmaceuticals Inc.
PRQR / ProQR Therapeutics N.V.
VKTX / Viking Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.